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Recent studies of  the group of hemolytic streptococci associated 
with  scarlet  fever  indicate  that  the  individual  strains  are  closely 
related  antigenically.  These  organisms  are  present  in  the  early 
stages of the disease in the throats of practically all individuals suf- 
fering  from  scarlet  fever.  In  addition, the  specific  streptococcus 
has been isolated from the uterine secretions in an undoubted instance 
of ISuerperal  scarlet fever, from the wound in a ease of wound scarlet, 
and from the local lesion in an instance of scarlet fever due to infec- 
tion  of  a  burn.  More  recently we  have  been  able  to  obtain  this 
streptococcus from the infected milk and  from patients in a  milk- 
borne  epidemic  of  scarlet  fever.  The  apparent  specificity  of  the 
organism and its  constant association with the disease again bring 
into prominence the question of its etiological relationship to scarlet 
fever.  The main objections of Jochmann to this etiological signifi- 
cance, namely that hemolytic streptococci are not present in all cases 
of scarlet fever, and that the type of streptococcus present is indis- 
tinguishable from hemolytic streptococci obtained from other patho- 
logical processes, can no longer be maintained. 
The importance of a  continued effort to decide the significance of 
this association of streptococcus with scarlet fever is obvious.  We 
have therefore continued the studies just mentioned with the hope 
of discovering additional evidence.  It is  probably of fundamental 
importance to determine beyond question the specificity of the type 
of  streptococcus  found in  scarlet  fever.  Up  to  the  present  time 
chief reliance  has  been  placed  upon  the  agglutination reaction  as 
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a  test of specific  serological  relationship.  This  reaction while ser- 
viceable is especially likely for a  variety of  reasons previously dis- 
cussed  to  furnish  questionable  results  when used  in  the  study of 
Streptococcus  h6emolyticus.  The low  virulence of  the  streptococcus 
for  test  animals  interferes  with  cross-protection  experiments  so 
that this method cannot be used.  In the present study we have again 
employed the agglutination reaction and have attempted to confirm 
the results so  obtained by determining the capacity of the strains 
under observation to absorb  agglutinin specifically. 
Material  and  Methods.--The  strains  of Streptococcus  hcemolyticus 
used in  the present study were collected from a  variety of widely 
separated localities.  The majority were obtained from the throats 
of patients in the scarlet fever wards of the Willard Parker Hospital, 
New York.  A number of strains came from an outbreak of scarlet 
fever due  to  infected milk.  This  series includes a  strain obtained 
from the suspected milk supply.  In addition a  small  number  of 
cultures from Copenhagen, San Francisco, Chicago, and Baltimore 
were studied.  The cultures were obtained for the most part during 
the first few days of the disease.  Hemolytic streptococcus was present 
on the plates from the throat secretions in 87.5 per  cent of the in- 
dividuals examined.  This incidence figure is somewhat lower  than 
that of Bliss  (100 per cent) owing probably to the fact that some of 
the cultures were made later during the course of the disease than is 
desirable.  Previous studies have shown that hemolytic streptococcus 
is only constantly demonstrable when an examination is made during 
the first days of an attack of scarlet fever.  The technique of culti- 
vation and agglutination was the same as that previously described 
for Streptococcus hcemol.yticus by Dochez, Avery, and Lancefield and 
by Bliss. 
The immune serum used in  these  experiments was  prepared by 
inoculating rabbits intravenously first with heat-killed and then with 
living  broth  cultures.  The  serum  of  each  animal  was tested for 
the presence of natural  agglutinins  with  two  scarlatinal  and  two 
non-scarlatinal  strains  of  streptococcus  before  immunization was 
begun.  Rabbits  possessing  natural  agglutinins  for  streptococcus 
were  discarded.  The first two  series  of  inoculations  were  with 
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Each  series consisted of four inoculations and an interval of 4 days 
was  allowed  to  elapse  between  courses.  The  third  and  fourth 
series  consisted  of  similar  inoculation  with living  18  hour  broth 
cultures.  If  the  animal  lbst  weight  during  the  process  of  im- 
munization  it  was  necessary  to  decrease  the  dosage.  About  10 
days  after  the  last  inoculation  the  animals  were  bled  and  the 
agglutinin  titer  of  the  serum  determined.  The  agglutinins  in 
antiscarlatinal  sera  tend  to  deteriorate  rapidly  and  this  deterio- 
ration  is  greatly  accelerated  by  inactivation  at  56°C.  The  most 
clear-cut  reactions  are  obtained  when  freshly  prepared  serum 
is used in the tests.  The agglutinin for the strain used in immuniza- 
tion generally persists longer than that for other scarlatinal strains. 
On the other hand, the homologous reaction sometimes tends to di- 
minish at a time when the serum still agglutinates heterologous scar- 
latinal strains strongly.  In all probability this is due to the gradual 
loss  of the agglutinable properties of  the  strain  itself.  Very  few 
reactions in  which there is  any question of specificity occur when 
sera  are prepared and used in  the m~nner described.  The results 
of the study of the agglutination reactions of the strains described are 
presented in  Table  I. 
Table I is an arrangement of the agglutination reactions with strains 
of hemolytic streptococci obtained from cases of scarlet fever occurring 
in New York (N Y  1, 2, 3, 4  and 5), San Francisco (S F  1  and  2), 
Chicago (Chi 1 and 2), Baltimore (Bait 1),  and  Copenhagen, Den- 
mark (Den 1 and 2), during the winter of  1922-23.  Through  the 
courtesy of the New York State Department of Health we are able 
to  include reactions  with  strains  isolated  from  the  throats  of pa- 
tients and from milk (E 2340 to E 2406,  and E 2950) during a milk- 
borne epidemic of scarlet fever.  Strains V  1 and V 2 isolated from 
throat cultures of patients during the Boston epidemic of septic sore 
throat  were  obtained  from  The  Rockefeller  Institute  for Medical 
Research.  All  these strains except Strain E  2950,  the milk strain, 
were obtained from throat cultures.  Strains of pyogenic cocci, A, 
B, C,D, E, F, and G,  are  non-scarlet strains  isolated  from infected 
wounds. 
These strains are arranged with the corresponding immune sera in 
groups  according  to  the  sources  from  which  they  were  obtained. 256  BIOLOGY OF  STREPTOCOCCUS.  III 
Each reaction, represented by one of the numerals 1, 2, 3, or the letter 
C.,  is  the  result obtained by  agghtinating  with  two  immune  sera. 
TABLE  I. 
Cross-Agglutination of Strains of Streptococci Isolated from Clinical Cases of Scarlet 
Fever. 
Sera. 
Strains. 
E  2340 
E  2341 
E  2342 
E  2344 
E  2346 
E  2402 
E  2404 
E  2406 
E  2950 
Chi  1 
Chi 2 
SF1 
SF2 
Den 1 
Den 2 
Balt 1 
NY1 
NY2 
NY3 
NY4 
NY5 
A 
B 
C 
D 
E 
F 
G 
V1 
V2 
c. 
C. 
C. 
C. 
1  " 
2 
3  -- 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
o  o 
0  0 
I 
~( 
d 
I' 
0  1  o! 
2 
0 
1 
0 
0 
0 
1 
3 
3 
2 
1 
3 
0  0 
0  0 
0  0 
0  0 
-  0 
0 
0  0 
0  0 
C. 
0 
1 
0 
0 
0 
0 
0 
0 
1 
e~ 
C. 
C. 
C. 
C. 
~c 
1 
1 
1 
C. 
0 
0 
0 
0 
0 
0 
Since  these  immune  sera  usually  agglutinate  the  antigenic strains 
as heavily as  they agglutinate other strains of  the scarlet group, we 
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at a  time during immunization when complete agglutination occurs 
in dilutions of 1:1,280 and a  +  +  +  reaction in dilutions of 1:2,560 
with the antigenic strains.  This agglutination is designated by the 
letter C. in the table.  The numerals 2 and 3 indicate reactions which 
are complete as high as 1:320 or 1:640 respectively.  When the re- 
action is  not  complete in  any of the dilutions  or complete only in 
the lower tubes the degree of reaction is indicated by the numeral 1. 
Completely negative  reactions  are  indicated  by  zeros.  When no 
agglutination reaction was carried  out with  certain sera and strains 
in the cross-agglutination table,  the fact has been noted by a minus 
sign.  No reactions are included in  the  table  in  which the  control 
tubes show  more  than  a  +  reaction  in  a  1:80  dilution of normal 
rabbit serum. 
These  streptococcal immune sera are found to  agglutinate all  of 
the scarlet strains and with the exception of Serum N  Y  1, no agglu- 
tination occurs with strains of pyogenic cocci.  These reactions con- 
firm the previously reported work of Dochez and Bliss (1), Bliss (2), 
Gordon  (3),  and  Tunnicliff  (4),  and  substantiate their claim that 
strains  of  hemolytic  streptococci  obtained  from  scarlatina  differ 
biologically  from  pyogenic  streptococci.  On  account  of  the  wide 
distribution of the cases from which these strains were obtained, we 
believe that  this  group  of streptococci is  generally associated with 
scarlet  fever,  and  that  the  streptococci  with  which  these  authors 
worked  are  identical. 
Considerable importance is attached to the agglutination of Strains 
E  2340 to E  2950  since they were obtained both from patients and 
from the milk  during  a  milk-borne epidemic of scarlet fever.  We 
find that these strains are agglutinated by sera prepared by immuniz- 
ing  animals  with  other scarlet strains and that sera prepared  with 
these strains  agglutinate other streptococci of the scarlatinal group. 
These reactions identify them as scarlatinal strains and indicate that 
milk may be a source of contagion in scarlet fever.  Strains V  1 and 
V  2 do not agglutinate with any of the sera, showing that epidemics 
of streptococcus angina although  they are spread  through milk in- 
fection are caused by a streptococcus differing biologically from Strep- 
tococcus scarlatin¢. 258  BIOLOGY  OF STREPTOCOCCUS.  III 
These  strains  obtained  from  the  two  epidemics all  have  a  final 
hydrogen ion  concentration of less  than  pH  5.1,  indicating  an  in- 
fection of the  milk  with  human  rather  than  bovine  strains.  The 
antigenic properties  of these strains vary greatly.  Certain strains, 
such as N  Y  4  and 5, when used for immunization, always produce 
sera which agglutinate scarlatinal strains strongly, while other strains 
such as  Chi  2  have  given poor  or  mediocre sera.  Certain  strains 
likewise agglutinate more readily and  more heavily than  others of 
the group.  For example, Chi 2,  which has poor immunizing quali- 
ties, is agglutinated more strongly than any other strain.  Aside trom 
these permanent variations in the antigenic properties strains at times 
become  inagglutinable.  This  occurs  especially  after  a  number  of 
transfers in broth.  A number of the 0 reactions in the table can be 
explained in this way.  These inagglutinable strains are still  capable 
of stimulating the production of specific agglutinins in animals. 
We have found that  certain combinations of sera and strains are 
necessary for the successful absorption of agglutinin.  These combina- 
tions can usually be picked out by the speed of the reaction and the 
degree of agglutination.  Strains will absorb the agglutinin from sera 
which are fresh if the agglutination is  complete within  15  minutes 
at  55°C. 
By selecting sera  and  strains  which have  reacted vigorously we 
have been able to obtain a  series of absorption tests in which every 
strain is represented.  The serum is diluted 1:40 and absorbed twice 
at 55°C.  with the centrifuged bacteria from 250  cc. of culture.  In 
Tables II  to VII the results have been tabulated with the series of 
dilutions,  showing  the results  of agglutination  of a  serum and  the 
antigenic strain with the serum after heating at 55°C.  and after ab- 
sorption with scarlet and non-scarlatinal streptococci. FRANKLIN  A.  STEVENS  AND  A.  R.  DOCHEZ  259 
TABLE  II. 
Absorption  of Agglutinin.  Serum 1~  2950  Absorbed with Strains  E  2950,  B  1, 
S F 1, S  F 2, Chi 1, and Non-Scarlet Strain A. 
Serum. 
Control,  normal  serum ..................... 
Immune  Serum  E  2950 ..................... 
Heated  "  E  2950 ..................... 
Serum  E  2950  absorbed  with ................ 
"  ~'. 2950  "  "  .............. 
"  E  2950  "  "  . ............. 
"  E  2950  "  " 
"  E  2950  "  "  .............. 
"  E  2950  "  "  .............. 
Strain 
295 
31 
;F1 
;F2 
khl  1 
Titer of serum with Strain E  2950. 
Dilutions. 
0 
! 
2 
0 
0 
0 
0 
0 
0 
TABLE  III. 
Absorption  of Agg~tinin.  Serum  E  2950  Absorbed  with  Scarlatina  Strains  E 
2950, E 2340, E  2344, N  Y  2, N  Y 3, and Non-Scarlet Strain A. 
Control,  normal  serum ...................... 
Immune  Serum  E  2950 ...................... 
Heated  "  E  2950 ...................... 
Serum  E  2950  absorbed  with .................  E 
"  E  2950  "  "  ...............  E 
"  E  2950  "  "  ...............  E 
"  E  2950  "  "  ...............  N 
"  E  2950  "  "  ...............  N 
"  E  2950  "  "  ............... 
riin. 
2950 
234O 
Y3 
Titer of serum with Strain E  2950. 
Dilutions. 
o 
3 
2 
1 
2 
1 
2 
0 
2 
¢,Q  °.  .. 
0 
3  ! 
2  0 
0  0 
0  0 
C  0 
O  0 
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TABLE  IV. 
Absorption  of  Agglutinin.  Serum  S  F  1  Absorbed  with  Scarlet  Strains  S  F  1, 
S  F  2, B  1, and Non-Scarlet  Strain  C. 
Serum. 
Normal serum control  ...................... 
Immune  "  S  F1 ....................... 
Heated  "  S  F  1 ....................... 
Serum S F  1 absorbed with  ................. 
"  S F  1  "  "  ................ 
"  S  F  1  "  "  ................ 
"  S  F  1  "  "  ................ 
Strain. 
Titer of serum with Strain S F  l. 
Dilutions. 
I ° 
4 
3 
S F1  0 
SF2  0} 
B1  0 
C  3~ 
0  O]  0 
4  4[  4 
4  41  4  3 
o  o{o  o 
0  0  O!  0 
0  0  0  0 
31  31  2 
-5  a 
0  0 
4  3 
2 
0 
0 
0 
0 
TABLE  V. 
Absorption  of  Agglutinin.  Immune  Serum  Chi  2  Absorbed  with  Scarlet  Strains 
Cki I,  Cki 2, N  Y  1, and Non-Scarlet  Strain  C. 
Serum. 
Normal serum control ....................... 
Heated  "  Chi 2 ......................... 
Serum Chi 2 absorbed with  .................. 
"  Chi 2  "  "  .............. 
"  Clfi 2  "  "  " " 
"  Clfi 2  "  "  ................. 
Strain. 
chi 1 
Chi 2 
NY1 
C 
Titer of serum with Strain Chi 2. 
Dilutions. 
.¢2. 
0 
1 
0 
0 
0 
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TABLE  Vl. 
Absorption  of  Agglutinin.  Immune  Serum  B  1  Absorbed  with  Scarlet  Strains 
Balt 1, S  F  1, S  F  2, Den 2, and Non-Scarlet Strain G. 
Serum, 
Normal  serum  control ..................... 
Serum Balt  1 ............................. 
Heated  Serum Balt  1 ...................... 
Serum Balt  1 absorbed with ................ 
"  Balt  1  "  "  ............... 
"  Balt  1  "  "  ............... 
"  Balt  1  "  "  ............... 
"  Balt  1  "  "  ............... 
Titer of serum with Strain Balt I. 
Dilutions.  Strain. 
_,=  .~ 
0 
4 
3 
Balt  1  0 
SF1  0 
SF2  2  1 
Den  2  1  0 
G  2  3  0 
0  0  ~  0 
3  3  2  0 
2  2  1  1 
0  0  0  0 
0  0  0  0 
1  0  0  0 
0  0  0  0 
2  1  0 
TABLE  VII. 
Absorption  of  Agglutinin.  Serum  Den  2  Absorbed  with  Scarlet  Strains  Den  I, 
Den 2, and Non-Scarlet Strain D. 
Serum. 
Normal  serum control ....................... 
Serum Den 2 ............................. 
Heated  Serum Den  2 ...................... 
Serum Den  2  absorbed with ................ 
"  Den  2  "  "  ............... 
"  Den  2  "  "  ............... 
Strab 
Den 
Den 
D 
Titer of serum with Strain Den 2. 
Dilutions. 
0o 
2 
0  0 
0  0 
0  0 
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CONCLUSIONS. 
I.  Strains  of  hemolytic streptococci from  cases  of  scarlet  fever 
occurring  in  New  York,  San  Francisco,  Chicago,  Baltimore,  and 
Copenhagen,  Denmark, all  interagglutinate with  immune sera pre- 
pared with these strains. 
2.  Sera prepared  with  these strains  do  not agglutinate pyogenic 
streptococci or strains isolated from cases of septic  sore throat. 
3.  The strains obtained from the throats of patients from an epi- 
demic of scarlet fever and the strain from the milk responsible for 
this epidemic fall into the scarlatinal group according to these agglu- 
tination tests. 
4.  Absorption tests can be carried out with these strains and sera 
under proper conditions. 
5.  A  group  of  hemolytic  streptococci  biologically  distinct  from 
streptococci from other sources than scarlet fever is constantly asso- 
dated with  scarlatina.  They constitute a  group  of closely related 
streptococci which may be identified by agglutination  tests. 
We are indebted to Dr. Matthias Nicoll and Dr. A. B. Wadsworth 
of  the  New  York  State  Department  of  Health,  to  Dr.  Ruth 
Tunnicliff of Chicago, to Miss Eugenia Valentine of San Francisco, 
and  to Dr.  Vilk. Jensen of Copenhagen for cultures of Streptococcus 
scarlatinee. 
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